e-therapeutics plc
Modulators of hedgehog (Hh) signaling pathway

Last updated:

Abstract:

There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD). ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

25 Oct 2017

Issue date:

30 Mar 2021